Skip to content

Category: Press Releases

Friends of Cancer Research CEO to Testify During First House PDUFA Reauthorization Hearing

The first House PDUFA reauthorization hearing is scheduled to take place at 10:15 am ET today, Wednesday, March 22, 2017, in the U.S. House of Representatives. Friends of Cancer Research President & CEO Dr. Jeff Allen will testify as to the importance of user fees during today’s hearing, along with FDA’s Dr. Janet Woodcock and…

NORD and Friends of Cancer Research Issue Joint Statement In Advance of This Week’s Congressional Hearings on FDA User Fees

Washington, D.C., March 21, 2017—The National Organization for Rare Disorders (NORD) and Friends of Cancer Research, two leading organizations that collectively represent millions of Americans with cancer and rare diseases, issued the following statement in advance of this week’s congressional hearings on the reauthorization of FDA user fees: “We wish to congratulate the Senate Committee…

President Nominates Dr. Scott Gottlieb for FDA Commissioner

President Nominates Dr. Scott Gottlieb for FDA Commissioner Friends Urges Swift Confirmation   Washington, DC, March 10, 2017 – Friends of Cancer Research (Friends) strongly supports President Trump’s nomination of Dr. Scott Gottlieb to serve as the next FDA Commissioner and urges Congress to work quickly to confirm his appointment.   “We deeply respect Dr. Gottlieb and have…

Major Action in Final Days of 114th Congress & Obama Administration

Historic Innovation Bill to be Signed Into Law: House, Senate & White House, Unified, Pass Major Bipartisan Action in Final Days of the 114th Congress & Obama Administration Bill Secures Future of Vice President’s Cancer Moonshot Washington, DC – December 7, 2016 – Friends of Cancer Research (Friends) applauds Congress and the White House for…

HESI THRIVE Network Selected as Partner for the Cancer Moonshot Task Force

Collaborative Program Will Provide Support for Quality-of-Life Research for Cancer Survivors Vice President Joe Biden released today a final report on the Cancer Moonshot Task Force, naming the Health and Environmental Sciences Institute’s (HESI’s) THRIVE Network as a participant in the Moonshot’s efforts to further advance the task force’s goals. The Moonshot program is focused…

Friends and Parker Institute for Cancer Immunotherapy Co-Host Summit: Optimizing the Use of Immunotherapy

October 5, 2016 – Washington, DC – Today, Friends of Cancer Research (Friends) is co-hosting a summit with the Parker Institute for Cancer Immunotherapy titled, Optimizing the Use of Immunotherapy. The summit will bring together more than 50 leaders who are pioneering the field of immuno-oncology from across the country.  The goal is to identify…

Friends' Managing Director, Ryan Hohman, Named Organization's First Vice President

Washington, DC – October 4, 2016 –  Friends of Cancer Research (Friends) announced today that Ryan Hohman, JD, who previously served as Managing Director, has been named Vice President – Public Affairs. This promotion is part of a larger organizational growth strategy that was initiated with the August announcement of Jeff Allen, PhD, becoming President…

Friends of Cancer Research Celebrates 20th Anniversary

Honors Dr. Janet Woodcock, Dr. Eric Lander, and Mr. Sean Parker for Contributions to Cancer Research Washington, DC, September 21, 2016 –  Friends of Cancer Research (Friends) will celebrate its 20th anniversary today at a special event in Washington DC. The event will honor Dr. Janet Woodcock, Dr. Eric Lander, and Mr. Sean Parker. During…

Friends' President and CEO Jeff Allen to Testify Before Congress

Allen Called Upon to Discuss LDT Use in Precision Medicine Washington, DC, September 20, 2016 – Today, Friends of Cancer Research (Friends) President & CEO, Jeff Allen, PhD, will testify at a Senate hearing on the use of laboratory developed tests (LDTs) in precision medicine. The hearing, held by the Health Education Labor and Pensions…

Cancer Moonshot Blue Ribbon Panel Presents Recommendations to National Cancer Advisory Board

Washington, DC – September 7, 2016 – Today the Cancer Moonshot Blue Ribbon Panel, comprised of 28 world-class leaders from science, research, and patient advocacy, including Friends of Cancer Research’s (Friends) Chair and Founder Ellen Sigal, presented their recommendations for accelerating cancer research to the President’s National Cancer Advisory Board. The Blue Ribbon Panel authored…